Study to Assess the Efficacy of Medi-Tate iTind Device

Inclusion Criteria: * Subject signed informed consent prior to the performance of any study procedures. * Male with symptomatic BPH. IPSS symptom severity score above 10. Peak urinary flow of below 12 ml/sec * Prostate volume below 75 ml * Blood CBC and biochemistry up to two weeks before screening demonstrating: Normal values of the PT, PTT and INR tests (anticoagulants should be stopped according to GCP) * Subject that able to complete the study protocol. * Normal Urinalysis and urine culture Exclusion Criteria: * cardiac arrhythmias, cardiac disease including congestive heart failure, uncontrolled diabetes mellitus, significant respiratory disease, or known immunosuppression; * neurogenic bladder and/or sphincter abnormalities due to Parkinson's disease, multiple sclerosis, cerebral vascular accident, diabetes, etc.; * a post void residual (PVR) volume above 250 ml measured by ultrasound or acute urinary retention * compromised renal function (i.e., serum creatinine level above 1.8 mg/dl, or upper tract disease); * confirmed or suspected bladder cancer; * recent (within 3 months) cystolithiasis or hematuria; * urethral strictures, bladder neck contracture, Urinary bladder stones * or other potentially confounding bladder pathology; * an active urinary tract infection. * Enrolled in another treatment trial for any disease within the past 30 days. * previous rectal surgery (other than hemorrhoidectomy) or history of rectal disease if the therapy may potentially cause injury to sites of previous rectal surgery, e.g., if a transrectal probe is used; * previous pelvic irradiation or radical pelvic surgery; * previous prostate surgery, balloon dilatation, stent implantation, laser prostatectomy, hyperthermia, or any other invasive treatment to the prostate * Cancer that is not considered cured, except basal cell or squamous cell carcinoma of the skin (cured defined as no evidence of cancer within the past 5 years). * Subject has an interest in future fertility and is not willing to undergo fertility treatments whatsoever. * Any serious medical condition likely to impede successful completion of the study.